![inj intacept inj intacept](https://5.imimg.com/data5/SELLER/Default/2021/6/EV/TO/RD/128495512/delestrogen-injection-500x500-250x250.jpg)
Patients should be closely monitored for the development of signs and symptoms of infection during and after treatment with ETACEPT, including the possible development of tuberculosis in patients who tested negative for latent tuberculosis infection prior to initiating therapy. The risks and benefits of treatment with ETACEPT should be carefully considered prior to initiating therapy in patients with chronic or recurrent infection. Bacterial, viral and other infections due to opportunistic pathogens, including Legionella and Listeria.Empiric anti-fungal therapy should be considered in patients at risk for invasive fungal infections who develop severe systemic illness. Antigen and antibody testing for histoplasmosis may be negative in some patients with active infection. Patients with histoplasmosis or other invasive fungal infections may present with disseminated, rather than localized, disease. Invasive fungal infections, including histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, and pneumocystosis.Treatment for latent infection should be initiated prior to ETACEPT use.
![inj intacept inj intacept](https://5.imimg.com/data5/UQ/TU/MY-18174683/etacept-etanercept-injection-250x250.jpg)
Patients should be tested for latent tuberculosis before reference etanercept use and during therapy.
![inj intacept inj intacept](https://5.imimg.com/data5/SELLER/Default/2020/10/KH/UD/EU/9026891/intacept-25mg-injection-500x500.jpg)
Patients with tuberculosis have frequently presented with disseminated or extrapulmonary disease. Active tuberculosis, including reactivation of latent tuberculosis.Most patients who developed these infections were taking concomitant immunosuppressants such as methotrexate or corticosteroids.ĮTACEPT should be discontinued if a patient develops a serious infection or sepsis. Patients treated with ETACEPT are at increased risk for developing serious infections that may lead to hospitalization or death. Gastrointestinal Perforations, Surgery and Wound Healing Complications, and Haemorrhage Serious Infections We deal with in companies like Roche, BMS, MSD, Genzyme, Eli Lilly, Sanofi Aventis, J&J, Novartis, Dr.Reddy's, Natco Pharma, Cipla, Astra Zeneca etc.To be sold by retail on the prescription of a Registered Rheumatologist and Dermatologist only Blackbox Warning We offer products like Herceptin, Mabthera, Neupogen, Sutent, Gleevac, Navelbine, Neulstim, Velcade, Taxol, Paraplatin, Cancidas and many more. Some of the drugs are Imatinib - Docetaxel - Tamozolamide - Gemcitabine - Doxorubicin - Interferons (All) - Rituximab-Nimotuzumab - Filgrastim. The list of products we deal ranges from entry level drugs to last available drug. These drugs are mainly used in the treatment of Blood - Lung - Breast - Colorectal - Liver - Gastric - Head & Neck - Pancreatic - Prostate - Cervical - Uterine - ovarian & bone Cancers.
![inj intacept inj intacept](https://5.imimg.com/data5/KA/JJ/HC/SELLER-9306787/aempred-inj-250x250.jpeg)
We offer drugs having different drug delivery systems like liposomal - Peglated & nanotech drugs, Monoclonal Antibodies. We Offer complete range of Oncology (Anti-Cancer) products across all categories like - Chemotherapy - Radiotherapy - Soft tissues & Solid Tumors. As customer satisfaction plays an important role in the success of company, we put diligent efforts to win their confidence by offering quality & safe products. All the drugs are directly sourced from Manufacturer, hence no chance of Counterfeit Drugs. All these products are offered with multiple company choice with variable price range. We offer wide range of anti cancer drugs.